E. Polverino (Barcelona, Spain), C. Brightling (Leicester (Leicestershire), United Kingdom)
Pulmonary function outcomes one year after moderate to critical COVID-19 pneumonia
S. van der Sar (Breda, Netherlands), A. Flikweert (Breda, Netherlands), I. De Backer (Breda, Netherlands)
|   |
Persistent symptoms after Covid 19- 6 months follow-up after discharge
C. Calarasu (Craiova (Dolj), Romania), F. Nitu (Craiova (Dolj), Romania), C. Streba (Craiova (Dolj), Romania), R. Cioboata (Craiova (Dolj), Romania), A. Mihai (Orsova, Romania)
| |
Follow up outcome in COVID-19 patients with persistent symptoms from central India
A. Faye (Nagpur, India), R. Swarnakar (Nagpur, India), S. Gudhane (Nagpur, India), C. Singh (Nagpur, India)
| |
Pre-COVID-19 lung function in a general adult population between COVID-19 and non-COVID-19 cases
D. Lisik (Gothenburg, Sweden), B. Nwaru (Gothenburg, Sweden), H. Kankaanranta (Gothenburg, Sweden)
| |
Post covid-19 manifestations in the omicron wave
A. Imzil (Agadir, Morocco), Y. Essaid (Agadir, Morocco), H. Moubachir (Agadir, Morocco), H. Serhane (Agadir, Morocco)
| |
Identifiying patients who require respiratory follow up after hospital admission with COVID-19
J. Martinovic (LONDON, United Kingdom), K. Myall (LONDON, United Kingdom), D. Sivakumar (LONDON, United Kingdom), J. Meurling (LONDON, United Kingdom), D. Roque (LONDON, United Kingdom), D. Jackson (LONDON, United Kingdom), A. Hearn (LONDON, United Kingdom), A. Seedat (LONDON, United Kingdom), A. Robbins (LONDON, United Kingdom), P. Drakatos (LONDON, United Kingdom), A. West (LONDON, United Kingdom)
| |
Reasons for post-covid hospitalization- one year experience from Serbia
A. Milenkovic (Sremska Kamenica, Republic of Serbia), S. Maksimovic (Sremska Kamenica, Republic of Serbia), M. Ilic (Novi Sad, Republic of Serbia), J. Javorac (Novi Sad, Republic of Serbia), D. Kovacevic (Sremska Kamenica, Republic of Serbia), M. Cvetkovic (Sremska Kamenica, Republic of Serbia), N. Savic (Sremska Kamenica, Republic of Serbia)
| |
Fatigue in Long Covid-19 is associated to short hospitalization time and normal lung function
S. Sperling (Aarhus N, Denmark), A. Fløe (Aarhus N, Denmark), S. Leth (Aarhus N, Denmark), T. Gissel (Viborg, Denmark), A. Topcu (Horsens, Denmark), L. Kristensen (Gødstrup, Denmark), C. Hyldgaard (Silkeborg, Denmark), L. Dahl Sønderskov (Randers, Denmark), S. Jensen-Fangel (Aarhus N, Denmark), J. Schmid (Aarhus N, Denmark), H. Hoffmann (Aarhus N, Denmark), E. Bendstrup (Aarhus N, Denmark)
| |
Self-reported cognitive complaints in post-Covid-19 patients and its association to cognitive performance
Z. Ebadi (Nijmegen, Netherlands), J. Peters (Nijmegen, Netherlands), B. Van Den Borst (Nijmegen, Netherlands), R. Kessels (Nijmegen, Netherlands), J. Vercoulen (Nijmegen, Netherlands)
| |
Evaluation of respiratory muscle function using ultrasound in post Covid-19 patients with unexplained dyspnea
E. van Voorthuizen (Nijmegen, Netherlands), J. Peters (Nijmegen, Netherlands), H. Van Helvoort (Nijmegen, Netherlands), A. Stoffels (Nijmegen, Netherlands), N. Voermans (Nijmegen, Netherlands), H. Van Hees (Nijmegen, Netherlands), J. Doorduin (Nijmegen, Netherlands), B. Van Den Borst (Nijmegen, Netherlands), A. Stoffels (Nijmegen (GE), Netherlands)
| |
Evolution of pulmonary function, CT changes and respiratory symptoms 6-8 months after hospital admission with COVID-19 infection
J. Kent Bramer (London, United Kingdom), Y. Ong (London, United Kingdom), A. Draper (London, United Kingdom), S. Akbar (London, United Kingdom), R. Aul (London, United Kingdom)
| |
One-year kinetics of the humoral response following SARS-CoV-2 vaccination Among Maintenance Hemodialysis Patients
O. Wand (Ashkelon, Israel), N. Nacasch (Kfar Saba, Israel), S. Benchetrit (Kfar Saba, Israel), A. Bar-Shai (Tel Aviv, Israel), K. Cohen-Hagai (Kfar Saba, Israel)
| |
Alfa-1 antitrypsin after one year COVID-19 infection
B. Jimenez Rodriguez (Granada, Spain), J. Ceballos Gutiérrez (Murcia, Spain), E. Triviño Ibañez (Granada, Spain), J. Gutiérrez Fernández (Granada, Spain), A. Romero Ortiz (Granada, Spain), C. Morales García (Granada, Spain)
| |
Relation of pulmonary diffusing capacity decline to HRCT and VQ SPECT/CT findings at early follow-up after COVID-19. A prospective cohort study (The SECURe study)
T. Kromann Lund (Copenhagen, Denmark), T. Katzenstein (Copenhagen, Denmark), J. Christensen (Copenhagen, Denmark), A. Kalhauge (Copenhagen, Denmark), F. Rönsholt (Copenhagen, Denmark), D. Podlekavera (Copenhagen, Denmark), E. Arndal (Copenhagen, Denmark), R. Berg (Copenhagen, Denmark), T. Kjaer (Copenhagen, Denmark), A. Lebech (Copenhagen, Denmark), J. Mortensen (Copenhagen, Denmark)
| |
Oxygen home therapy after discharge of hospitalized patients with COVID-19
D. Belkhir (Tunis, Tunisia), H. Blibech (Tunis, Tunisia), H. Snene (Tunis, Tunisia), A. Jebali (Tunis, Tunisia), S. Daoud (Tunis, Tunisia), L. Kaabi (Tunis, Tunisia), S. Debbiche (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), S. Miladi (Tunis, Tunisia), A. Laatar (Tunis, Tunisia), N. Ben Salah (Tunis, Tunisia), B. Louzir (Tunis, Tunisia)
| |
Post discharge persistent dyspnea after covid-19 pneumonia
M. Jebali (tunis, Tunisia), H. Blibech (tunis, Tunisia), H. Snene (tunis, Tunisia), S. Daoud (tunis, Tunisia), D. Belkhir (tunis, Tunisia), L. Kaabi (tunis, Tunisia), S. Debbiche (tunis, Tunisia), N. Mehiri (tunis, Tunisia), N. Bensalah (tunis, Tunisia), B. Louzir (tunis, Tunisia)
| |
Predictive factors of persistent dyspnea after COVID-19 pneumonia
H. Cherif (Tunis, Tunisia), N. Guediri (Tunis, Tunisia), S. Kalboussi (Tunis, Tunisia), M. Triki (Tunis, Tunisia), F. Yangui (Tunis, Tunisia), M. Charfi (Tunis, Tunisia)
| |
Trajectories of respiratory recovery after severe SARS-CoV-2 infection (RE2COVERI): a pragmatic, longitudinal cohort study.
F. Schlemmer (Créteil Cedex, France), S. Valentin (Nancy, France), L. Boyer (Créteil Cedex, France), V. Bonnefoy (Créteil Cedex, France), C. Dupin (Paris, France), A. Bergeron (Paris, France), F. Chabot (Nancy, France), M. Zysman (Bordeaux, France), E. Blanchard (Bordeaux, France), M. Roumila (Le Chesnay, France), C. Colin (Le Chesnay, France), V. Giraud (Boulogne, France), E. Giroux-Leprieur (Boulogne, France), T. Gilles (Bobigny, France), Y. Uzunhan (Bobigny, France), P. Brillet (Bobigny, France), I. Honoré (Paris, France), N. Roche (Paris, France), M. Faure (Paris, France), M. Patout (Paris, France), C. Morelot-Panzini (Paris, France), S. Gunther (Paris, France), O. Sanchez (Paris, France), A. Ruppert (Paris, France), J. Cadranel (Paris, France), C. Andrejak (Paris, France), C. Jung (Créteil, France), E. Bugnet (Créteil, France), F. Canoui-Poitrine (Créteil, France), B. Maitre (Créteil, France)
| |
Circulating calprotectin correlates with DLCO in patients four months after COVID-19
C. Machahua Huamani (Bern, Switzerland), N. Abu Hussein (Bern, Switzerland), M. Horn (Bern, Switzerland), T. Geiser (Bern, Switzerland), M. Funke-Chambour (Bern, Switzerland)
| |
Bronchoalveolar lavage fluid characteristics in patients with persistent symptoms following COVID-19 infection
M. Gysan (Vienna, Austria), A. Lehmann (Vienna, Austria), D. Bernitzky (Vienna, Austria), M. Christopher (Vienna, Austria), A. Zech (Vienna, Austria), H. Prosch (Vienna, Austria), M. Idzko (Vienna, Austria), D. Gompelmann (Vienna, Austria)
| |